Recently, adenoviruses expressing the IFN-β gene were examined for the anti-tumor effects on mesothelioma in an animal model, and were clinically investigated for the safety and the therapeutic feasibility in mesothelioma patients [12,13]. The gene discussed is IFNB1; the disease is mesothelioma.